Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).
about
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.Glia and alpha-synuclein in neurodegeneration: A complex interactionInflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Mitochondrial genome changes and neurodegenerative diseasesClassification and Characteristics of Pain Associated with Parkinson's DiseasePain management in patients with Parkinson's disease: challenges and solutionsParkinson's disease as a result of agingGenomics and bioinformatics of Parkinson's diseaseMitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression.Evaluation of alpha-synuclein immunohistochemical methods used by invited expertsEnvironmental neurotoxin-induced progressive model of parkinsonism in rats.Glycoproteomics in neurodegenerative diseases.Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacityComparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease.A Life-Long Approach to Physical Activity for Brain Health.Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carbolineFunctional reorganization of the locomotor network in Parkinson patients with freezing of gait.Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.Targeting impulsivity in Parkinson's disease using atomoxetineOlfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's diseasePathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions.Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia.Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease.Nicotine as a potential neuroprotective agent for Parkinson's disease.Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease.Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivoMilestones in research on the pathophysiology of Parkinson's diseaseThe neuropathological basis for depression in Parkinson's disease.Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy.Peptidoglycan recognition protein genes and risk of Parkinson's disease.Distinct populations of neurons respond to emotional valence and arousal in the human subthalamic nucleusTraumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.
P2860
Q24633663-8D0437D9-AD48-4236-9962-48F236FD7375Q26851153-C70471FC-05CE-46F9-B3AC-A199B3731B5CQ27022728-02392047-A69A-4320-92C9-86E60ED5C240Q27023750-2B667F20-4042-43C6-91A4-4645EC7E5FB5Q28066313-C4B95E84-6458-4B45-BCD1-BBA72D3D9483Q28067204-96E0A961-2BE1-45E5-A780-0CBFDE820FE0Q28084395-53A4B40F-90AF-438D-9378-8B3B12F50692Q28727855-A8D6FF4B-AF5C-4B24-ABDF-7A6A4CD88AD2Q30422362-FBC91B79-CA3F-4C75-AFB4-2E10BEC530F8Q30488694-9B9AABD2-1B65-4762-81AD-134C5D0C91E4Q30497416-674A4935-BF3F-4BB1-B977-D13C3D410B57Q33563387-2F9D10C9-19AC-42CB-BB0D-3B0F6F8C1C1EQ33617472-465F5092-FC91-4DF8-9E85-B232902B2305Q33693692-462B0C84-EBFB-4E38-8F34-A31A95EFF83BQ33715695-AE2B3B82-E96F-4B66-B33A-2B7DA0905AB4Q33724885-3FAC2113-3928-4B97-ADEC-86A6C04A36BBQ33759944-3D80ADF1-2FB7-4B54-883E-449C4F51259FQ33769132-D6A3D18D-DE43-4DF5-AB00-4E05A25C169DQ33773655-D6BD3BE2-C9FC-4048-B270-E54EC459C0E7Q33784038-8859CC36-26C6-4559-A02F-53E511558FDCQ33882719-8CECB069-9F64-4C3B-8951-2640F5F223F0Q33891870-BB30818E-A54A-4D8E-A509-DA8C67D3C5ACQ33896828-E2239640-8222-4682-9A65-BC177577E63BQ34100703-92D4A68F-4338-4AF7-974F-589173124059Q34165820-655D8A99-CBC7-4888-BC7A-C752BA82CB5AQ34235667-C251D7B3-AC14-463C-BE34-E18D57C93648Q34281003-6CA54943-244A-4CD1-B2D0-701EB34472B9Q34470963-AEC61C15-DA81-40B9-8A74-55D49065E708Q34534524-CE60BBD1-3EF9-4A44-BD27-7EC3FBB457E2Q34555482-2AA48BDF-50D2-435A-9EC5-0FAA85D26218Q34595165-423A54CA-5A9F-4822-8EBE-716040F836BAQ34639246-7C48C271-7BDB-4F80-84CE-32C60EB25D66Q34749047-FC9EB92C-7407-4A57-BC8C-77CE0FABDE4EQ34764454-76C2CA2F-B4D7-44AF-A6D8-0583F9C9ACADQ35075257-D6B22B1C-F28A-4C54-9673-41387E3A1767Q35170538-CE683E66-09D5-407C-85E0-83235FC6D915Q35189966-32C47F76-0D3F-4DC1-9790-8BABB81DEFD9Q35212580-7525B573-7C0C-4CBE-8036-F41BBC81348BQ35264378-AE2317D7-046E-49D0-8489-F3B5F0A4E276Q35287117-C0112525-75B7-49C9-8C21-051943CC296E
P2860
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Staging of the intracerebral i ...... clinical and clinical stages).
@en
type
label
Staging of the intracerebral i ...... clinical and clinical stages).
@en
prefLabel
Staging of the intracerebral i ...... clinical and clinical stages).
@en
P2093
P1433
P1476
Staging of the intracerebral i ...... eclinical and clinical stages)
@en
P2093
Daniele Sandmann-Keil
Hansjürgen Bratzke
Heiko Braak
John Hamm-Clement
Kelly Del Tredici
P2888
P304
P356
10.1007/S00415-002-1301-4
P478
249 Suppl 3
P577
2002-10-01T00:00:00Z